MAPK11 antibody (AA 334-359)
Quick Overview for MAPK11 antibody (AA 334-359) (ABIN3031829)
Target
See all MAPK11 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 334-359
-
Purpose
- MAPK11 Antibody
-
Purification
- Purified
-
Immunogen
- A portion of amino acids 334-359 from the human protein was used as the immunogen for this MAPK11 antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Titration of the MAPK11 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the MAPK11 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- MAPK11 (Mitogen-Activated Protein Kinase 11 (MAPK11))
-
Alternative Name
- MAPK11
-
Background
- P38 beta is a member of the MAP kinase subfamily of Ser/Thr protein kinases. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is closely related to p38 MAP kinase, both of which can be activated by changes in osmolarity of the extracellular environment, proinflammatory cytokines and cellular stress. This protein preferentially phosphorylates transcription factor ATF2. It is activated by phosphorylation on threonine and tyrosine by MKK6, and inhibited by pyridinyl-imidazole related compounds. Highest levels of expression are found in the brain and heart, with additional expression in the placenta, lung, liver, skeletal muscle, kidney and pancreas.
-
UniProt
- Q15759
-
Pathways
- MAPK Signaling, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Response to Water Deprivation, Regulation of Muscle Cell Differentiation, ER-Nucleus Signaling, Hepatitis C, Toll-Like Receptors Cascades, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, BCR Signaling, S100 Proteins
Target
-